Vergara, Maxcryl Klenmae M.
HRN: 21-91-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
CEFTRIAXONE 1G (VIAL)
10/20/2022
10/27/2022
IV
2gm
OD
UTI, Leukocytosis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes